Jump to content

Abionic

Edit links
From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by GermanJoe (talk | contribs) at 10:53, 17 July 2018 (→‎Recognition and awards: + hidden note for clarity). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Abionic SA
Company typePrivate
IndustryMedtech, in vitro diagnostics
Founded2010 in Lausanne, Switzerland
FoundersDr. Nicolas Durand & Dr. Iwan Märki
Headquarters
Lausanne
,
Switzerland
ProductsabioSCOPE
Websitewww.abionic.com

Abionic SA is a Swiss medtech company headquartered in Lausanne, specialized in medical devices and in vitro diagnostics.[1] The device has tests including the sensitization to common respiratory allergies by measuring a patient's Immunoglobulin E (IgE) levels, iron deficiency tests, as well as tests for sepsis risk assessment and management.[2]

History

The company was founded in 2010 as a spinoff from the École Polytechnique Fédérale de Lausanne (EPFL, Swiss Federal Institute of Technology of Lausanne), by Dr. Nicolas Durand and Dr. Iwan Märki. In 2012 the company received ISO 13485 certification and the diagnostic platform, the abioSCOPE, was certified.[3] In 2015 the first range of respiratory allergen diagnotics was developed and placed on the market.[4] In 2016 the Ofac group was selected as Abionic's first distributor for the Swiss pharmacy market.[5]

In 2017 the company received CE marking for its ferritin and sepsis tests.[6] Abionic sponsored World Sepsis day, in order to raise awareness of sepsis on behalf of the Global Sepsis Alliance.[7] Abionic obtained U.S. Food and Drug Administration registration for their first set of respiratory allergy diagnostics.[8]

Products

The abioSCOPE is a medical device that does immunoassay tests based on the ELISA principle.[9] It can run diagnostic tests for allergies, for iron deficiency and it can determine the level of risk that a patient has in developing sepsis.[10]

Recognition and awards

Year Name of competition Rank Location
2010 PERL (Prix Entreprendre Région Lausanne) 1st [11] Lausanne
DebioPharm Award for Life sciences 1st [12] Switzerland
KPMG Inspiration Winner [13] Switzerland
Venture Kick Winner of all 3 stages [14] Switzerland
2011 DeVigier Winner [15] Switzerland
2012 European Academic Enterprise Awards 2012 [16] 2nd Europe
Venture (Phase 2 Business Plan)[17] 6th Switzerland
Red Herring top 100 best European Startups [18] Winner Europe
2013 Swiss Excellence Product Award Winner [19] Switzerland
Best Elevator Pitch Award[20] Winner Luxembourg
2016 Swiss Economic Forum Finalist [21] Switzerland
2017 Finance Monthly Game Changers Awards Winner [22] Switzerland

References

  1. ^ SEF4KMU (January 2017) "La platforme de diagnostic la plus rapide au monde", www.sef4kmu.ch
  2. ^ Venturelab, "Abionic Receives CE Mark for Most Rapid Sepsis and Iron Deficiency Point of Care Diagnostics", www.venturelab.ch
  3. ^ Venture Kick (March 2012) "Abionic décroche ses certifications qualité", www.venturekick.ch, retrieved March 2018
  4. ^ Venturelab (May 2015), "Abionic starts the commercialization of its revolutionary diagnostic platform", www.venturelab.ch
  5. ^ Corset J.-M. (January 16 2017) "Abionic déménage à Epalinges et étend sa gamme de tests", 24 heures, p.9
  6. ^ Clinical Lab Products (February 7 2017) "POC Tests for Sepsis, Iron Deficiency, Get CE Mark", www.clpmag.com
  7. ^ Global Sepsis Alliance (July 2017) "The GSA Welcomes Abionic as the Newest Sponsor of World Sepsis Day", www.global-sepsis-alliance.org
  8. ^ Ouyang B. (October 2017) "Abionic Detects Your Allergies in Minutes", www.medgadget.com
  9. ^ Chapman, M.D., Wuenschmann, S., King, E., & Pomés, A., (2015), "Technological Innovations for High-Throughput Approaches to In Vitro Allergy Diagnosis", National Center for Biotechnology Information, U.S. National Library of Medicine
  10. ^ Monti, A., (January 2017), "The bloodiest that detects killer SEPSIS in five minutes: Revolutionary treatment could save thousands of lives, and may soon be introduced in the NHS", Daily Mail, www.dailymail.co.uk
  11. ^ Newsletter.epfl.ch (2010) "TROPHEES PERL 2010PRIX ENTREPRENDRE REGION LAUSANNE"
  12. ^ Debiopharm Group Press Release (November 2010) "Abionic wins the ‘Prix Debiopharm Valais pour les Sciences de la Vie", www.debiopharm.com
  13. ^ Startupticket.ch (December 2011) "Abionic représentera l’EPFL pour le prix Européen Academic Enterprise", www.startupticker.ch
  14. ^ Startupticket.ch (December 2011) "Abionic représentera l’EPFL pour le prix Européen Academic Enterprise", www.startupticket.ch
  15. ^ W.A. De Vigier Stiftung (2011) "Biosensors for a multimillion-dollar market", www.devigier.ch
  16. ^ Venture Kick (December 2012) "Abionic und Optotune im Finale der ACES Awards 2012", www.venturekick.ch
  17. ^ Venture (2012) "TEAMS 2012 – WINNERS PHASE 2", www.venture.ch
  18. ^ Red Herring (2012) "Europe 2012 Top 100", www.redherring.com
  19. ^ Venturelab (2013) "Des venturelab alumni récompensés au "Swiss Excellence Product Award"", www.venturelab.ch
  20. ^ Venture Kick (April 2013) ""Abionic gewinnt den „Best Elevator Pitch Award”", www.venturekick.ch
  21. ^ Swiss Economic Forum (2016) "Finalisten 2016 - Hightech/Biotech", swisseconomic-2017.cmsbox.ch
  22. ^ Finance Monthly (2017) "Game Changers Awards 2017" p.6, www.finance-monthly.com
Retrieved from "https://en.wikipedia.org/w/index.php?title=Abionic&oldid=850674956"